Concepedia

Michael Rosenzweig

MR

Statistics

Publications

69

Citations

7.7K

H-Index

41

Active since

1974

Affiliations

City of Hope(Current)

Harvard University

New England Biolabs (United States)

Massachusetts General Hospital

Emory University

Michael Rosenzweig is an author at City of Hope specializing in life sciences, immunology, and hematology.

ORCID

Publications per year

1974–2025

69

Publications

69

Gastrointestinal Tract as a Major Site of CD4 <sup>+</sup> T Cell Depletion and Viral Replication in SIV Infection

Ronald S. Veazey, MaryAnn DeMaria, Laura V. Chalifoux et al. · Science · 1998 · 1.4K citations

, , +13

Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species

Margaret A. Goodell, Michael Rosenzweig, Hyung L. Kim et al. · Nature Medicine · 1997 · 1.1K citations

, , +11

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

, , +15

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial

Vaishali Sanchorawala, Daniel G. Wright, Michael Rosenzweig et al. · Blood · 2006 · 259 citations · Full text

, , +5

In vivo CAR T cell generation to treat cancer and autoimmune disease

Theresa Hunter, Yanjie Bao, Yan Zhang et al. · Science · 2025 · 228 citations

, , +17

1–5 of 69